Simcere Pharmaceutical Group Limited (FRA:S2P)
Germany
· Delayed Price · Currency is EUR 1.460
0.00 (0.00%)
At close: Dec 5, 2025
FRA:S2P Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,867 | 2,195 | 2,039 | 3,710 | 2,664 | 2,462 | Upgrade
|
| Market Cap Growth | 79.43% | 7.63% | -45.02% | 39.23% | 8.23% | - | Upgrade
|
| Enterprise Value | 3,691 | 1,945 | 1,877 | 3,525 | 2,617 | 2,829 | Upgrade
|
| Last Close Price | 1.46 | 0.81 | 0.73 | 1.28 | 0.89 | - | Upgrade
|
| PE Ratio | 36.96 | 22.63 | 22.37 | 29.38 | 12.77 | 29.36 | Upgrade
|
| PS Ratio | 4.58 | 2.50 | 2.42 | 4.32 | 3.85 | 4.36 | Upgrade
|
| PB Ratio | 4.50 | 2.35 | 2.21 | 3.83 | 2.98 | 3.68 | Upgrade
|
| P/TBV Ratio | 5.70 | 2.81 | 2.51 | 4.16 | 3.10 | 3.89 | Upgrade
|
| P/FCF Ratio | 31.34 | 16.04 | - | 27.04 | - | - | Upgrade
|
| P/OCF Ratio | 23.32 | 11.93 | 105.83 | 20.19 | - | 203.24 | Upgrade
|
| EV/Sales Ratio | 4.29 | 2.22 | 2.23 | 4.11 | 3.78 | 5.01 | Upgrade
|
| EV/EBITDA Ratio | 19.52 | 10.83 | 15.90 | 31.86 | 44.76 | 29.79 | Upgrade
|
| EV/EBIT Ratio | 24.09 | 12.97 | 20.69 | 42.85 | 81.03 | 37.66 | Upgrade
|
| EV/FCF Ratio | 29.92 | 14.21 | - | 25.69 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.17 | 0.17 | 0.20 | 0.21 | 0.25 | 0.62 | Upgrade
|
| Debt / EBITDA Ratio | 0.79 | 0.84 | 1.43 | 1.72 | 3.50 | 4.10 | Upgrade
|
| Debt / FCF Ratio | 1.19 | 1.17 | - | 1.49 | - | - | Upgrade
|
| Asset Turnover | 0.58 | 0.59 | 0.61 | 0.60 | 0.47 | 0.51 | Upgrade
|
| Inventory Turnover | 1.91 | 1.80 | 2.84 | 4.01 | 3.59 | 2.94 | Upgrade
|
| Quick Ratio | 1.53 | 1.73 | 1.76 | 1.69 | 1.51 | 1.48 | Upgrade
|
| Current Ratio | 1.73 | 2.00 | 2.10 | 1.84 | 1.63 | 1.85 | Upgrade
|
| Return on Equity (ROE) | 12.45% | 10.26% | 9.94% | 13.62% | 25.41% | 19.49% | Upgrade
|
| Return on Assets (ROA) | 6.50% | 6.33% | 4.11% | 3.62% | 1.38% | 4.23% | Upgrade
|
| Return on Capital (ROIC) | 9.55% | 8.37% | 5.13% | 4.52% | 1.74% | 5.74% | Upgrade
|
| Return on Capital Employed (ROCE) | 13.90% | 12.90% | 8.70% | 7.80% | 3.30% | 8.10% | Upgrade
|
| Earnings Yield | 2.71% | 4.42% | 4.47% | 3.40% | 7.83% | 3.41% | Upgrade
|
| FCF Yield | 3.19% | 6.23% | -2.08% | 3.70% | -2.14% | -1.30% | Upgrade
|
| Dividend Yield | 1.35% | 2.61% | 2.80% | 1.69% | 2.33% | - | Upgrade
|
| Payout Ratio | 45.61% | 54.76% | 58.65% | 42.04% | 25.96% | - | Upgrade
|
| Buyback Yield / Dilution | 4.18% | 3.40% | 0.45% | -0.34% | -9.14% | -2.03% | Upgrade
|
| Total Shareholder Return | 5.53% | 6.01% | 3.25% | 1.34% | -6.81% | -2.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.